Inotek Pharmaceuticals Corp (ITEK): Great Point Partners Adds to Its Position

Page 5 of 10 – SEC Filing

CUSIP No.  45780V102	13G	Page 5 of 9 Pages

Item 1.
	(a)       Name of Issuer            Inotek Pharmaceuticals Corp
	(b)       Address of Issuer’s Principal Executive Offices            91 Hartwell Ave, 2nd FL, Lexington MA 02421
Item 2.
	(a)       Name of Person Filing Great Point Partners, LLC Dr. Jeffrey R. Jay, M.D. Mr. David Kroin The Reporting Persons have entered into a Joint Filing Agreement, dated January 3, 2017, a copy of which is filed with this Schedule 13G as Exhibit A, pursuant to which the Reporting Persons have agreed to file this statement jointly in accordance with the provisions of Rule 13d-1(k)(1) under the Act.
	(b)       Address of Principal Business Office, or if none, Residence The address of the principal business office of each of the Reporting Persons is 165 Mason Street, 3rd Floor Greenwich, CT 06830
	(c)       Citizenship Great Point Partners, LLC is a limited liability company organized under the laws of the State of Delaware. Dr. Jeffrey R. Jay, M.D. is a citizen of the United States. Mr. David Kroin is a citizen of the United States.
	(d)       Title of Class of Securities            Common Stock
	(e)       CUSIP Number            45780V102
Item 3.	If this statement is filed pursuant to §240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
	(a) [_] Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o)
	(b) [_] Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c).
	(c) [_] Insurance company as defined in Section 3(a)(19) of the Act (15. U.S.C. 78c).
	(d) [_] Investment Company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
	(e) [X] An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E).
	(f) [_] An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F).